Featured Research

from universities, journals, and other organizations

Stanford Trial Studies Vastly Shorter Radiation Time For Breast Cancer Treatment

Date:
November 22, 2002
Source:
Stanford University Medical Center
Summary:
A new radiation approach being tested at Stanford University Medical Center could shorten the overall treatment time for women with breast cancer. Participants will receive a single dose of radiation at the time of surgery rather than the usual six-week course of radiation therapy. The clinical trial is now recruiting patients.

STANFORD, Calif. - A new radiation approach being tested at Stanford University Medical Center could shorten the overall treatment time for women with breast cancer. Participants will receive a single dose of radiation at the time of surgery rather than the usual six-week course of radiation therapy. The clinical trial is now recruiting patients.

"The trial should tell us whether this accelerated form of radiotherapy is safe, feasible and effective in controlling cancer recurrence in the breast for certain women who have a lumpectomy," said Frederick Dirbas, MD, assistant professor of surgical oncology at the Stanford School of Medicine and leader of the trial.

Women with a breast tumor often have a lumpectomy, surgery in which the doctor removes only the cancerous region, leaving the rest of the breast intact. The patient then receives a dose of radiation to the entire breast each weekday for about the next six weeks to minimize the risk of cancer returning.

"The fact that current radiation treatments occur every day for several weeks makes it an issue for women," Dirbas said, adding that the schedule can be inconvenient for women who work, care for young children or live far from the treatment site. He said the idea behind this prolonged schedule was that women would experience fewer side effects if the total radiation dose was broken into smaller increments.

In recent years, however, doctors in the United States and Europe have begun looking at approaches to shorten the overall treatment time while still fending off cancer. In one Italian trial with more than 100 participants, patients received a single large dose of radiation at the same time as the surgery. Two years after the initial surgery, the treatment appears to be safe and effective.

Based on this success, Dirbas and Donald Goffinet, MD, professor of radiation oncology, are replicating the Italian trial - the first U.S. trial of this technique. They hope to recruit 50 women who are older than 40, have a single breast tumor that is smaller than 2.5 centimeters and have a low likelihood of tumors elsewhere in the breast.

For information about participating in the trial, please call Janelle Maxwell at 650-498-7740.


Story Source:

The above story is based on materials provided by Stanford University Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Stanford University Medical Center. "Stanford Trial Studies Vastly Shorter Radiation Time For Breast Cancer Treatment." ScienceDaily. ScienceDaily, 22 November 2002. <www.sciencedaily.com/releases/2002/11/021122074540.htm>.
Stanford University Medical Center. (2002, November 22). Stanford Trial Studies Vastly Shorter Radiation Time For Breast Cancer Treatment. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2002/11/021122074540.htm
Stanford University Medical Center. "Stanford Trial Studies Vastly Shorter Radiation Time For Breast Cancer Treatment." ScienceDaily. www.sciencedaily.com/releases/2002/11/021122074540.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins